Navigation Links
Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
Date:6/4/2008

SAN DIEGO, June 4 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President and CEO Theodore Schroeder will present the corporate overview on Wednesday, June 11, 2008 at 3:00 pm Eastern Time (12:00 pm Pacific Time) during the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference at the New York Palace Hotel in New York City.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at http://www.cadencepharm.com in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 90 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III product candidates in development, Acetavance(TM) (intravenous acetaminophen) for the treatment of acute pain and fever, and Omigard(TM) (omiganan pentahydrochloride 1% topical gel) for the prevention of catheter-related infections. For more information about Cadence's pipeline, visit http://www.cadencepharm.com.

Cadence(TM), Acetavance(TM) and Omigard(TM) are trademarks of Cadence Pharmaceuticals, Inc.

Contacts: William R. LaRue Anna Gralinska


'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008
2. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview
3. Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
4. Cadence Pharmaceuticals Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference
5. Antipodean Pharmaceuticals Announces FDA Acceptance of IND for MitoQ(R)
6. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
7. Vion Pharmaceuticals Announces Presentation of Data from Phase III Trial of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
8. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
9. Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
10. Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
11. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... (PRWEB) September 16, 2014 ... information media site, launches their new site today. ... additional features aimed at making information easier to ... sift, we distill into one-page, easy-to-read pages the ... should know!” says Virginia Downie, retired college professor ...
(Date:9/16/2014)... 2014 The Living Ethics lecture series ... Reflecting on what it means to live in an ... unique and thought-provoking topics. , “The Museum’s job is ... look at their world differently. The Living Ethics ... for truly enlightening dialogue,” says Richard Conti, Chief Wonder ...
(Date:9/16/2014)... Banish headaches forever with the newest ... device for chronic migraine relief and treatment. Cefaly was ... States. Until now, US patients would directly place their ... and wait 2-3 weeks for their device to arrive. ... and once prescription and payment is received, the Cefaly ...
(Date:9/16/2014)... Recently, BamboofloorChina.com, a famous online supplier of bamboo products, ... bamboo panels . The firm is now offering ... its high quality items. Please note that the big ... 2014. , According to the company’s chief executive ... should visit BamboofloorChina.com before September 28. BamboofloorChina.com is offering ...
(Date:9/15/2014)... 16, 2014 Career Step, an ... training, is pleased to announce that Panacea Healthcare ... PCS comprehensive skill assessments and the ICD-10-CM and ... and Panacea’s consulting division. , “We are excited ... ICD-10 to our clients,” said Suzanne Lappen, Panacea ...
Breaking Medicine News(10 mins):Health News:JustThoughtYouShouldKnow.org Debuts New Website 2Health News:Expanding Community Vision at the Science Museum of Virginia 2Health News:Cefaly Migraine Treatment Device Now Readily Available For Widespread Purchase in United States 2Health News:Cheap Bamboo Panels Unveiled By Famous Online Supplier BamboofloorChina.com 2Health News:Panacea Healthcare Solutions to Resell Career Step’s ICD-10-CM and PCS Assessments and Case Studies 2Health News:Panacea Healthcare Solutions to Resell Career Step’s ICD-10-CM and PCS Assessments and Case Studies 3
... more attention be paid after hospital discharge, , , MONDAY, ... the veterans treated in Veterans Affairs hospitals suffer from ... suicide than non-depressed veterans, University of Michigan researchers report. ... and might it be related to their use of ...
... conjunction with its fourth quarter 2008 earnings release (expected to be issued after ... is pleased to invite you to listen to its quarterly investor conference call ... at 9:00 a.m. ET., What: Covance Fourth ... Presentation, When: ...
... Outdoor Recreation Participation StudyFindings include increase in overall ... The Outdoor Foundation today announced the ... Report, the only detailed study of its ... The findings highlighted in the report are areas ...
... Club is hosting a,Pharmacy Challenge and Savings Checkup in ... check prices on their prescriptions and,over-the-counter medications against other ... on branded prescriptions. Membership is not,required to use ... "Your Healthy Year" promotes a variety of ways consumers ...
... FRANCISCO, Jan. 12 Within health care, dermatology,professionals play ... , The Dermatology Nurses, Association ... practice in a variety,of learning formats and the opportunity ... annual conference slated for March,4-7 at the Hilton San ...
... CYBX ) today announced that Milton ... Research and Development, effective on January 12, 2009. ... company,s development programs. Dr. Morris joins Cyberonics from ... company in North Carolina, where he has served ...
Cached Medicine News:Health News:With Depression, Vets Face Higher Suicide Risk 2Health News:With Depression, Vets Face Higher Suicide Risk 3Health News:As Childhood Obesity Rates Rise, Youth Outdoor Participation Declines 2Health News:As Childhood Obesity Rates Rise, Youth Outdoor Participation Declines 3Health News:Sam's Club(R) Hosts Pharmacy Challenge 2Health News:Hop the Trolley for DNA's 27th Annual Conference 2Health News:Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development 2Health News:Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development 3Health News:Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development 4
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire-iReach/ -- MedicOne Medical Response, ... services, has been selected by Inc. Magazine as ... America. Photo - http://photos.prnewswire.com/prnh/20140914/145997 ... list identifies successful, privately-held companies with the largest ... Response, one of only two ambulance companies to ...
(Date:9/15/2014)... /PRNewswire-iReach/ -- CaPtivate Pharmaceuticals LLC, a ... (CaP)-based nanoparticle drug and vaccine delivery technologies, announced ... Agreement with Immunotope Inc., another Pennsylvania ... the treatment and prevention of viral infections and ... the agreement, Immunotope is granted a non-exclusive world-wide ...
(Date:9/15/2014)... The Society of Corporate Compliance and ... than 4,500 compliance and ethics professionals from across ... corporate fines and settlements.  The SCALENDAR is designed ... ready reference to demonstrate to employees the consequences ... to help compliance and ethics officers looking for ...
Breaking Medicine Technology:MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 3CaPtivate Pharmaceuticals Enters License Agreement With Immunotope 2CaPtivate Pharmaceuticals Enters License Agreement With Immunotope 3More than $55 billion in fines and settlements added by SCCE to its 2015 Corporate Scandal Calendar 2
... , WAYNE, N.J. and EMERYVILLE, Calif., Dec. ... Inc. (Nasdaq: ONXX ) today announced results ... 2 trials were presented at the 32nd Annual ... of these studies evaluated Nexavar® (sorafenib) tablets in ...
... , BATESVILLE, Ind., Dec. 11 Hill-Rom (NYSE: ... use in medical-surgical areas of hospitals and care facilities. The new bed ... to use a variety of care surfaces as needed. , "Hill-Rom ... the best features of Hill-Rom,s long-time leader, the Advanta bed, with many ...
Cached Medicine Technology:Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 2Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 3Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 4Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 5Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 6Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 7Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 2Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 3Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 4
The ELISA test is used for detection and semi quantitation of igG antibodies to proteinase 3(PR3) in human sera, as an aid to the diagnosis is of Wegener's granulomatosis....
... Acolytes core technology relates to the ultrasensitive ... found in all living cells. ATP ... using bioluminescence. By coupling AK ... via extraction using antibody-coated beads, Acolyte can ...
... DYONICS POWERMAX Shaver Handpiece has 25% more ... standard Smith & Nephew handpiece providing optimal ... handling and reduced hand fatigue. ,The forward/reverse ... suction lever are all co-located to allow ...
... tailored to individual needs. The pump can ... Indeed a Shaver unit only is featured ... and handpiece.,The REVOLUTION shaver system features a ... progressive motor (up to 4.000 rpm). When ...
Medicine Products: